One study conducted among obese individuals without diabetes reported that prolonged (6 months) TNF inhibition significantly decreased fasting glucose and increased adiponectin, probably reflecting improved insulin sensitivity (46). The gene discussed is ADIPOQ; the disease is diabetes mellitus.